AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Cytomegalovirus glycoprotein elicits antibody response in macaques.

Vaccine Weekly

| June 02, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Rhesus cytomegalovirus glycoprotein B elicits an antibody response in naturally infected rhesus macaques.

"Rhesus cytomegalovirus (RhCMV) exhibits strong parallels with human CMV (HCMV) in terms of nucleic and amino acid identities, natural history, and mechanisms of persistence and pathogenesis in its natural host, rhesus macaques (Macaca mulatta). To determine whether this non-human primate model would be useful to assess vaccine strategies for HCMV, host immune responses to RhCMV glycoprotein B (gB) were evaluated in RhCMV-infected monkeys. Total protein extracts were prepared from cells transiently transfected with an expression plasmid for either the full-length gB or a derivative (gBDelta, 1-680 aa) lacking both the transmembrane domain and cytoplasmic tail," scientists in the United States report.

"Western blot analysis showed identical reactivity of macaque sera with full-length gB and its derivative gBDelta, indicating that the immunodominant epitopes of gB are contained in the extracellular portion of the protein," stated Yujuan Yue and colleagues at the University of California-Davis. "Using gBDelta extract as a solid phase, a sensitive and specific ELISA was established to characterize gB antibody responses in monkeys acutely and chronically infected with RhCMV. During primary infection (seroconversion), gB-specific antibodies developed concurrently and in parallel with total RhCMV-specific antibodies.

"However, during chronic infection ...

Related articles from newspapers, magazines, journals, and more
Thiourea molecule inhibits cytomegalovirus glycoprotein-mediated fusion.
Newspaper article from: Biotech Week March 17, 2004 700+ words
...thiourea small molecule inhibited human cytomegalovirus glycoprotein B-mediated fusion. "A novel small...Virology (Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea...
CMV glycoprotein B genotype does not affect CNS disease risk.
Newspaper article from: Mental Health Weekly Digest January 26, 2004 700+ words
...To investigate any association between cytomegalovirus glycoprotein B (CMV gB) subtypes and central nervous...in the Journal of Medical Virology (Cytomegalovirus glycoprotein B genotypes and central nervous system...
New cytomegalovirus research from Fukushima Medical University, Department of...
Newspaper article from: Virus Weekly August 26, 2008 700+ words
...highly conserved region in the human cytomegalovirus glycoprotein H gene and design of molecular diagnostic...highly conserved region in the human cytomegalovirus glycoprotein H gene and design of molecular diagnostic...
Scientists at National Yang-Ming University, Department of Internal Medicine...
Newspaper article from: Virus Weekly August 26, 2008 700+ words
...report 'The type-2 variant of human cytomegalovirus glycoprotein N (gN-2) is not the rarest in the...Methods (The type-2 variant of human cytomegalovirus glycoprotein N (gN-2) is not the rarest in the...
NABI, Chiron start donor stimulation for CMV NeutraGam; plan Phase I clinical...
Newspaper article from: Transplant News May 15, 1996 700+ words
NABI, Inc., Boca Raton, FL, announced the start of donor stimulation for CMV NeutraGam (cytomegalovirus glycoprotein B immune globulin intravenous) (human), the first product to emerge from NABI's collaborative agreement with Chiron...
Data from University of Tubingen advance knowledge in immunology.
Newspaper article from: Immunotherapy Weekly September 2, 2009 700+ words
...pattern similar to ULBP2. However, although ULBP2 strongly binds both NKG2D and the immunoevasive human cytomegalovirus glycoprotein UL16, RAET1G only weakly interacts with NKG2D and does not bind UL16. Differential binding capacities...
NABI STARTS DONOR STIMULATION IN PREPARATION FOR PHASE I TRIALS OF CMV...
Press release article from: PR Newswire May 8, 1996 700+ words
...NABI, (Nasdaq: NABI) announced today the start of donor stimulation for CMV NeutraGAM(TM), (cytomegalovirus glycoprotein B immune globulin intravenous (human) [CMVIG]) the first product to emerge from NABI's collaborative...
Study findings from M.K. Isaacson et al provide new insights into...
Newspaper article from: Virus Weekly May 19, 2009 700+ words
...from infected cells." Isaacson and colleagues published their study in the Journal of Virology (Human Cytomegalovirus Glycoprotein B Is Required for Virus Entry and Cell-to-Cell Spread but Not for Virion Attachment, Assembly, or...
For more facts and information, see all results

Source: HighBeam Research, Cytomegalovirus glycoprotein elicits antibody response in macaques.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA